Functional knee bracing after quadriceps ACL reconstruction

Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial (BRACE-trial)

Not applicable Interventional Wake Forest University Health Sciences · NCT06942754

This trial will test whether wearing a functional knee brace after quadriceps-tendon ACL reconstruction helps young athletes and military personnel return to sport and reduces graft failures over two years.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment96 (estimated)
Ages14 Years to 39 Years
SexAll
SponsorWake Forest University Health Sciences Academic / other
Locations1 site (Winston-Salem, North Carolina)
Trial IDNCT06942754 on ClinicalTrials.gov

What this trial studies

This is a randomized controlled trial comparing postoperative functional bracing versus no bracing in patients undergoing quadriceps autograft ACL reconstruction. Participants are athletic or military patients aged 14–39 with a unilateral complete ACL tear who plan to return to sport or duty. Outcomes measured over two years include psychological readiness, patient-reported outcome measures, clinical stability, return-to-sport rates, and graft failure. The study is conducted at Wake Forest University Health Sciences and excludes patients with multiligament injuries, prior ACL surgery, significant osteoarthritis, or other conditions that would affect rehabilitation.

Who should consider this trial

Good fit: Ideal candidates are athletic or military patients aged 14–39 with a unilateral complete ACL tear undergoing quadriceps autograft reconstruction who want to return to sport or duty.

Not a fit: Patients with multiligament injuries, prior ACL surgery, significant osteoarthritis, major malalignment, fractures, pregnancy, or comorbidities affecting rehabilitation are excluded and unlikely to benefit from the intervention tested here.

Why it matters

Potential benefit: If successful, functional bracing could reduce graft failures and improve knee stability, confidence, and return-to-sport rates after quadriceps ACL reconstruction.

How similar studies have performed: Surveys and previous studies have reported mixed results and no clear consensus on functional bracing after ACL reconstruction, and there are no prior randomized trials specifically focused on quadriceps grafts and psychological readiness.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients with unilateral complete ACL injury
* patients involved in sports and the desire to return to sports
* patients undergoing quadriceps autograft ACL reconstruction
* must be 14 to 39 years old

Exclusion Criteria:

* multiligamentous knee injuries defined as two ligaments requiring surgical stabilization
* concomitant suture tape augmentation, extra-articular tenodesis or anterolateral ligament reconstruction
* concomitant femoral, tibial, or patellar fracture(s)
* patients with significant osteoarthritis
* concomitant ipsilateral knee dislocation or patellar dislocation
* significant lower leg malalignment requiring correcting osteotomies
* prior ACL surgery, including contralateral knee
* pregnancy during injury or surgery
* unable to provide consent
* prolonged use of prednisolone or cytostatics
* comorbidities (e.g., muscular, neurological, vascular) that influence rehabilitation

Where this trial is running

Winston-Salem, North Carolina

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Anterior Cruciate Ligament InjuriesAnterior Cruciate Ligament reconstructionpostoperative bracingfunctional bracing
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.